Pipeline
R&DB of antiviral drugs
| Target | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|
| Pipeline I
(Brovir) |
Safety & PK testing |
Single-dose, repeat, genetic, carcinogenicity, PK/PK, ADME, etc |
||||
| Pet cats |
In vitro Efficacy test |
Apply for clinical trial plan & clinical trials on cats |
Application for product approval & launch of prototype |
|||
| Pet dogs |
In vitro Efficacy test |
Apply for clinical trial plan & clinical trials on dogs |
Application for product approval |
|||
| Humans |
Phase 1 clinical trial |
Phase II clinical trial |
||||